Brief: Herantis Pharma To Focus On CDNF And xCDNF Programs

Herantis Pharma Oyj

29/03/2021 19:03

March 29 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * HERANTIS PHARMA TO FOCUS ON CDNF AND XCDNF PROGRAMS
    * HERANTIS PHARMA - BOARD DECIDED TO COMMENCE SEEKING
OUT-LICENSING PARTNERS FOR LYMFACTIN(®) PROGRAM IN TREATMENT OF
BREAST CANCER RELATED LYMPHEDEMA

Source text for Eikon:  ID:nWkr4CX1RC 
Further company coverage:  HRTIS.HE 

 ((Reuters.Briefs@thomsonreuters.com;))